Kenvue Inc.
KVUENYSE · SIC 2844
$18.98
↓ -0.2%Jul 17 close · end-of-day
Price
1Y↓ -9.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$36.5B
Enterprise Value
$35.4B
P/E
22.6
P/S
2.4
P/B
3.4
EV/EBITDA
11.1
PEG
—
FCF Yield
5.0%
Dividend Yield
4.4%
Revenue (TTM)
$15.3B
Net Income (TTM)
$1.6B
Free Cash Flow (TTM)
$1.8B
Gross Margin
58.4%
Operating Margin
17.2%
Net Margin
10.6%
ROE
15.3%
ROIC
20.2%
Debt / Equity
0.0
Net Cash
$1.1B
Return 1Y
-9.1%
Company profile
We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.
- CEO
- Thibaut Mongon
- Sector
- Manufacturing
- Industry
- Consumer Goods
- Headquarters
- New Jersey
- Website
- www.jnj.com/kenvue/
Management & directors
- Howlett HeatherVP & Chief Accounting Officer
- Orlando MatthewGeneral Counsel
- Curado Gomes De Lemos LeonardoGroup President LATAM
- Alvarado LuaniChief People Officer
- Lawson CarltonGroup President EMEA & LA
- Stevens MeredithChief Operations Officer
- Dyer RussellChief Corp. Affairs Officer
- Perry KirkChief Executive Officer
- Tillett CarolineChief Scientific Officer
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-08-06
KVUE Q1 2026 Earnings
Period ends 2026-03-29
MetricActualYoY
Revenue$3.9B↑ +4.5%
Diluted EPS$0.25↑ +47.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $15.1B | $14.9B | $15.4B | $15.5B | $15.1B |
| Gross profit | $8.4B | $8.3B | $8.6B | $9.0B | $8.8B |
| Operating income | $2.9B | $2.7B | $2.5B | $1.8B | $2.4B |
| Net income | $2.1B | $2.1B | $1.7B | $1.0B | $1.5B |
| Diluted EPS | $1.21 | $1.20 | $0.90 | $0.54 | $0.76 |
| Operating cash flow | $334.0M | $2.5B | $3.2B | $1.8B | $2.2B |
| Free cash flow | $39.0M | $2.1B | $2.7B | $1.3B | $1.7B |
| Gross margin | 55.9% | 55.4% | 56.0% | 58.0% | 58.1% |
| Operating margin | 19.4% | 17.9% | 16.3% | 11.9% | 16.0% |
| Net margin | 13.8% | 13.8% | 10.8% | 6.7% | 9.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0B | $3.9B | $3.7B | $3.7B | $3.8B | $3.8B | $3.8B | $3.9B |
| Gross profit | $2.4B | $2.3B | $2.1B | $2.2B | $2.3B | $2.2B | $2.1B | $2.3B |
| Operating income | $154.0M | $654.0M | $483.0M | $558.0M | $692.0M | $629.0M | $535.0M | $767.0M |
| Net income | $58.0M | $383.0M | $293.0M | $322.0M | $420.0M | $398.0M | $330.0M | $474.0M |
| Diluted EPS | $0.03 | $0.20 | $0.16 | $0.17 | $0.22 | $0.21 | $0.16 | $0.25 |
| Operating cash flow | $440.0M | $249.0M | $793.0M | $428.0M | $621.0M | $294.0M | $854.0M | $489.0M |
| Free cash flow | $350.0M | $190.0M | $661.0M | $249.0M | $533.0M | $196.0M | $744.0M | $350.0M |
| Gross margin | 59.1% | 58.5% | 56.5% | 58.0% | 58.9% | 59.1% | 56.5% | 58.9% |
| Operating margin | 3.9% | 16.8% | 13.2% | 14.9% | 18.0% | 16.7% | 14.2% | 19.6% |
| Net margin | 1.5% | 9.8% | 8.0% | 8.6% | 10.9% | 10.6% | 8.7% | 12.1% |
Company news
Jul 14, 2026
Jul 13, 2026
- 7d agoSector Update: Healthcare Stocks Advance Late Afternoonfinance.yahoo.com
- 7d agoKVUE Stock Dips After Court Revives Tylenol Autism Lawsuitsstocktwits.com
- 7d agoTop Midday Stories: Trump Says US to Be Guardian of Hormuz Strait; Meta to Invest Over $50 Billion in Louisiana Data Center Expansionfinance.yahoo.com
- 7d agoTylenol-Maker Kenvue Must Face Autism Claims, Appeals Court Saysfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-10 | Howlett Heather· CFO & CAO | Sale | 3,700 | $18.11 | $66,988.50 | filing |
| 2026-05-08 | Orlando Matthew· General Counsel | Sale | 38,491 | $17.66 | $679,690.85 | filing |
| 2026-05-01 | Curado Gomes de Lemos Leonardo· Group President LATAM | Tax withholding | 7,141 | $17.43 | $124,467.63 | filing |
| 2026-05-01 | Curado Gomes de Lemos Leonardo· Group President LATAM | Option exercise | 24,248 | $0.00 | $0.00 | filing |
| 2026-03-10 | Stevens Meredith· Chief Operations Officer | Tax withholding | 1,738 | $17.96 | $31,214.48 | filing |
| 2026-03-10 | Alvarado Luani· Chief People Officer | Tax withholding | 1,721 | $17.96 | $30,909.16 | filing |
| 2026-03-10 | Stevens Meredith· Chief Operations Officer | Tax withholding | 358 | $18.16 | $6,501.28 | filing |
| 2026-03-10 | Alvarado Luani· Chief People Officer | Tax withholding | 357 | $18.16 | $6,483.12 | filing |
| 2026-03-10 | Alvarado Luani· Chief People Officer | Option exercise | 3,525 | $0.00 | $0.00 | filing |
| 2026-03-10 | Stevens Meredith· Chief Operations Officer | Option exercise | 4,329 | $0.00 | $0.00 | filing |
| 2026-03-10 | Stevens Meredith· Chief Operations Officer | Option exercise | 840 | $0.00 | $0.00 | filing |
| 2026-03-10 | Alvarado Luani· Chief People Officer | Option exercise | 697 | $0.00 | $0.00 | filing |
| 2026-03-10 | Lawson Carlton· Group President EMEA & LA | Option exercise | 6,158 | $0.00 | $0.00 | filing |
| 2026-03-05 | Alvarado Luani· Chief People Officer | Tax withholding | 2,094 | $18.25 | $38,215.50 | filing |
| 2026-03-05 | Stevens Meredith· Chief Operations Officer | Tax withholding | 1,677 | $18.25 | $30,605.25 | filing |
| 2026-03-05 | Howlett Heather· VP & Chief Accounting Officer | Tax withholding | 933 | $18.25 | $17,027.25 | filing |
| 2026-03-05 | Howlett Heather· VP & Chief Accounting Officer | Option exercise | 2,723 | $0.00 | $0.00 | filing |
| 2026-03-05 | Lawson Carlton· Group President EMEA & LA | Option exercise | 7,736 | $0.00 | $0.00 | filing |
| 2026-03-05 | Alvarado Luani· Chief People Officer | Option exercise | 4,289 | $0.00 | $0.00 | filing |
| 2026-03-05 | Stevens Meredith· Chief Operations Officer | Option exercise | 6,178 | $0.00 | $0.00 | filing |
| 2026-03-03 | Howlett Heather· VP & Chief Accounting Officer | Tax withholding | 526 | $18.15 | $9,546.90 | filing |
| 2026-03-03 | Howlett Heather· VP & Chief Accounting Officer | Option exercise | 1,534 | $0.00 | $0.00 | filing |
| 2026-02-13 | Lawson Carlton· Group President EMEA & LA | Option exercise | 34,907 | $18.66 | $651,364.62 | filing |
| 2026-02-13 | Stevens Meredith· Chief Operations Officer | Tax withholding | 7,147 | $18.66 | $133,363.02 | filing |
| 2026-02-13 | Alvarado Luani· Chief People Officer | Tax withholding | 4,843 | $18.66 | $90,370.38 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.